Peripheral blood gamma-delta T cells in advanced-stage cancer patients

Advances in Therapy

Volumn 25, Issue 3, 2008, Pages 218-224

  Bilgi, Oguz ^a   Karagoz, Bülent ^a   Turken, Orhan ^a   Kandemir, E Gokhan ^a   Ozturk, Ahmet ^a   Gumus, Mahmut ^b   Yaylaci, Mustafa ^b  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b Department of Medical Oncology   (Turkey)

Author keywords

Gamma delta cell; Immunity; T cell

Indexed keywords

LIPOCORTIN 5; NATURAL KILLER CELL RECEPTOR NKG2D; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR DELTA CHAIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD SAMPLING; BREAST CANCER; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; KIDNEY CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MALE; METASTASIS POTENTIAL; PROTEIN EXPRESSION; STOMACH CANCER; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

AGED; ANNEXIN A5; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 59249083465     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-008-0032-z     Document Type: Article

References (21)

1. Street SE, Hayakawa Y, Zhan Y, et al. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells. J Exp Med. 2004;199:879-884.
2. Kabelitz D, Wesch D, Pitters E, Zoller M. Potential of human gammadelta T lymphocytes for immunotherapy of cancer. Int J Cancer. 2004;112:727-732.
3. Davis MM, Boniface JJ, Reich Z, et al. Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol. 1998;16:523-544.
4. Kabelitz D, Glatzel A, Wesch D. Antigen recognition by human gammadelta T lymphocytes. Int Arch Allergy Immunol. 2000;122:1-7.
5. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat Immunol. 2000;1:119-126.
6. Bauer S, Groh V, Wu J, Steinle A, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285:727-729.
7. Mukasa A, Lahn M, Fleming S, et al. Extensive and preferential fas/fas ligand-dependent death of gammadelta T cells following infection with listeria monocytogenes. Scand J Immunol. 2002;56:233-247.
8. Zheng BJ, Chan KW, Im S, et al. Anti-tumor effects of human peripheral gammadelta T cells in a mouse tumor model. Int J Cancer. 2001;92:421-425.
9. Sireci G, Espinosa E, Di Sano C, Dieli F, Fournie JJ, Salerno A. Differential activation of human gammadelta cells by nonpeptide phosphoantigens. Eur J Immunol. 2001;31:1628-1635.
10. Sicard H, Al Saati T, Delsol G, Fournie JJ. Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma. Mol Med. 2001;7:711-722.
11. Wilhelm M, Kunzmann V, Eckstein S, et al. Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood. 2003;102:200-206.
12. Mroz RM, Kowal E, Ossolinska M. Selective increase of gamma delta T lymphocytes in peripheral blood of patients with pulmonary tuberculosis according to the kind and stage of disease [in Polish]. Pneumonol Alergol Pol. 1996;64:723-728.
13. Kobayashi H, Tanaka Y, Yagi J, Toma H, Uchiyama T. Gamma/delta T cells provide innate immunity against renal cell carcinoma. Cancer Immunol Immunother. 2001;50:115-124.
14. Bas M, Bier H, Schirlau K, et al. Gammadelta T-cells in patients with squamous cell carcinoma of the head and neck. Oral Oncol. 2006;42:691-697.
15. De Libero G, Casorati G, Giachino C, et al. Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells. J Exp Med. 1991;173:1311-1322.
16. Haas W, Pereira P, Tonegawa S. Gamma/delta cells. Annu Rev Immunol. 1993;11:637-685.
17. Barnes PF, Grisso CL, Abrams JS, Band H, Rea TH, Modlin RL. Gamma delta T lymphocytes in human tuberculosis. J Infect Dis. 1992;165:506-512.
18. Ottones F, Dornand J, Naroeni A, Liautard JP, Favero J. V Gamma 9v delta 2 T cells impair intracellular multiplication of brucella suis in autologous monocytes through soluble factor release and contactdependent cytotoxic effect. J Immunol. 2000;165:7133-7139.
19. Zocchi MR, Ferrarini M, Migone N, Casorati G. T-cell receptor V delta gene usage by tumour reactive gamma delta T lymphocytes infiltrating human lung cancer. Immunology. 1994;81:234-239.
20. Guo BL, Liu Z, Aldrich WA, Lopez RD. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells. Breast Cancer Res Treat. 2005;93:169-175.
21. Liu Z, Guo BL, Gehrs BC, Nan L, Lopez RD. Ex vivo expanded human vgamma9vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro. J Urol. 2005;173:1552-1556.